Diurnal Variation in Rectal Diameter
1 other identifier
observational
30
1 country
1
Brief Summary
The purpose of the study is to determine the diurnal variation of rectal diameter in healthy and constipated children using transabdominal ultrasound.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 27, 2012
CompletedFirst Posted
Study publicly available on registry
September 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedNovember 16, 2012
November 1, 2012
1 month
September 27, 2012
November 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rectal diameter
24 hours
Study Arms (2)
Healthy
Transabdominal ultrasound
Constipated
Transabdominal ultrasound
Interventions
Transabdominal ultrasound are applied to the subjects every third hour during the study and every hour for three hours after a bowel movement.
Eligibility Criteria
Constipated children are recruited from the outpatient clinic at Kolding pediatric department. A list of patients which have been given the diagnose constipation are drawn from the computer and reviewed. Children between 4-12 years who fulfill the Rome III criteria of constipation and have been taking PEG maintenance treatment at least 1 month, are contacted by telephone for possible participation in the study. Healthy participants without constipation or other diseases affecting the gastrointestinal tract were recruited among the employees of the Department of Pediatrics at Kolding Hospital. Written informed consent was obtained from both parents before any procedures were initiated.
You may not qualify if:
- Children with known organic causes of constipation, including Hirschsprungs disease, spinal and anal congenital abnormalities, previous surgery on the colon, inflammatory bowel disease, allergy and metabolic or endocrine diseases.
- Children receiving drugs known to affect bowel function during a 2 month period before initiation besides laxatives.
- Children between 4 and 12 years of age.
- Children with known organic causes of constipation, including Hirschsprungs disease, spinal and anal congenital abnormalities, previous surgery on the colon, inflammatory bowel disease, allergy and metabolic or endocrine diseases.
- Children receiving drugs known to affect bowel function during a 2 month period before initiation.
- Children with a previous history of constipation, fecal incontinence and / or urinary tract infections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Line Modinlead
- University of Southern Denmarkcollaborator
Study Sites (1)
Pediatric department, Kolding Hospital
Kolding, 6000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Line Modin, MD
Kolding Sygehus
- STUDY DIRECTOR
Marianne Jakobsen, MD, phd
Kolding Sygehus
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
September 27, 2012
First Posted
September 28, 2012
Study Start
September 1, 2012
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
November 16, 2012
Record last verified: 2012-11